penicillamine and cyclofenil

penicillamine has been researched along with cyclofenil in 5 studies

Research

Studies (5)

Timeframe	Studies, this research(%)	All Research%
pre-1990	1 (20.00)	18.7374
1990's	2 (40.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (40.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V	1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K	1
Herbai, G	1
Akesson, A; Blom-Bülow, B; Scheja, A; Valind, S; Wollheim, FA; Wollmer, P	1
Akesson, A; Hørslev-Petersen, K; Scheja, A	1

Reviews

1 review(s) available for penicillamine and cyclofenil

Article	Year
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans. Drug discovery today, 2016, Volume: 21, Issue:4 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk	2016

Trials

1 trial(s) available for penicillamine and cyclofenil

Article	Year
Long-term evaluation of penicillamine or cyclofenil in systemic sclerosis. Results from a two-year randomized study. Scandinavian journal of rheumatology, 1992, Volume: 21, Issue:5 Topics: Adult; Aged; Cyclofenil; Electrocardiography; Esophagus; Exercise; Female; Heart; Humans; Immune System; Kidney; Lung; Male; Middle Aged; Penicillamine; Prospective Studies; Scleroderma, Systemic; Skin; Time Factors; Ventilation-Perfusion Ratio	1992

Article

Year

Long-term evaluation of penicillamine or cyclofenil in systemic sclerosis. Results from a two-year randomized study.

Scandinavian journal of rheumatology, 1992, Volume: 21, Issue:5

Topics: Adult; Aged; Cyclofenil; Electrocardiography; Esophagus; Exercise; Female; Heart; Humans; Immune System; Kidney; Lung; Male; Middle Aged; Penicillamine; Prospective Studies; Scleroderma, Systemic; Skin; Time Factors; Ventilation-Perfusion Ratio

1992

Other Studies

3 other study(ies) available for penicillamine and cyclofenil

Article	Year
FDA-approved drug labeling for the study of drug-induced liver injury. Drug discovery today, 2011, Volume: 16, Issue:15-16 Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration	2011
Scleroderma (progressive systemic sclerosis, PSS); pathophysiological, clinical and pharmacological aspects of the syndrome. Acta medica Academiae Scientiarum Hungaricae, 1978, Volume: 35, Issue:3-4 Topics: Cyclofenil; Humans; Male; Middle Aged; Penicillamine; Scleroderma, Systemic; Skin	1978
Serum levels of aminoterminal type III procollagen peptide and hyaluronan predict mortality in systemic sclerosis. Scandinavian journal of rheumatology, 1992, Volume: 21, Issue:1 Topics: Cyclofenil; Female; Humans; Hyaluronic Acid; Male; Penicillamine; Peptide Fragments; Procollagen; Prognosis; Radioimmunoassay; Scleroderma, Systemic; Time Factors	1992